Clinical Trial: C-TIL051 in Non-Small Cell Lung Cancer
Study Status: NOT_YET_RECRUITING
Recruit Status: NOT_YET_RECRUITING
Condition: Metastatic Non Small Cell Lung Cancer
Study Type: INTERVENTIONAL
Official Title: C-TIL051 in Anti-PD1 Resistant Metastatic Non-Small Cell Lung Cancer
Brief Summary:
The goal of this Phase 1 clinical study is test tumor infiltrating lymphocytes (known as C-TIL051) with NKTR-255 and anti-PD1 therapy for subjects with refractory non-small cell lung cancer.The purpose of this study is to:Test the safety and ability for subjects to tolerate the TIL therapyMeasure to see how the NSCLC responds to the TIL therapyParticipants will be asked to:Provide a tumor sample prior to the start of any treatment which will be used to make the C-TIL051.Receive standard of care treatment until…
Read more